Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • National Synovial Sarcoma Tumor Board
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Latest News

    Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager

    December 12, 2025 joshs Comments Off on Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager
    A woman with shoulder-length brown hair and a yellow top smiles softly indoors, with sunlight streaming through large windows covered by bamboo blinds and white curtains in the background.

    Current Patient to Drive Relationships and Support for the Synovial Sarcoma Community

    [Philadelphia, PA] – 12/12/25 – The Synovial Sarcoma Foundation (SSF) is thrilled to announce the appointment of Julie Kramer as our new Community Engagement & Partnerships Manager. With a wealth of experience in advocacy and nonprofit communications, and as a survivor of synovial sarcoma, Julie is uniquely equipped to support the foundation’s mission and the needs of our patient community.

    Diagnosed in 2014, Julie navigated her diagnosis through multiple treatments and has been NED (No Evidence of Disease) since 2017 after being treated for her third recurrence. Her journey has empowered her to advocate for others facing similar challenges, making her a meaningful voice within the cancer community. Julie’s commitment to educating and supporting those affected by synovial sarcoma was showcased on national television when she appeared on The Ellen DeGeneres Show, bringing awareness to this rare cancer.

    In her new role at SSF, Julie will work to strengthen research collaborations and industry partnerships, expand outreach to patients and caregivers, and enhance engagement within our growing community. Her resilience and passion for support will be pivotal as the foundation continues its mission to improve the lives of those affected by synovial sarcoma.

    A collage of five images showing a woman at various stages: smiling, with a young child outside, in a hospital gown with medical equipment, in bed post-surgery, and with a group at a cancer center reception.

    “We are honored to welcome Julie to our team,” said Chas Spence, Executive Director of the Synovial Sarcoma Foundation. “Her personal experience and professional expertise will be invaluable as we strive to create a supportive network for patients and their families facing this challenging diagnosis.”

    The Synovial Sarcoma Foundation encourages everyone in the community to join us in welcoming Julie Kramer. We are grateful for the heart, experience, and hope she brings to our organization.

    For additional information about Julie or the Synovial Sarcoma Foundation, please visit SynovialSarcoma.org.

    You can learn more about Julie’s journey by following her on Instagram.

    joshs

    Post navigation

    Previous

    Search

    Categories

    • Black Flag Racing (2)
    • CHOP (3)
    • Development (2)
    • Dr. Theodore Laetsch (3)
    • Education (2)
    • Healthcare (1)
    • Latest News (3)
    • Research (8)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (2)
    • Teresa Belluco (1)
    • Tumor Board (2)
    • Uncategorized (1)

    Recent posts

    • A woman with shoulder-length brown hair and a yellow top smiles softly indoors, with sunlight streaming through large windows covered by bamboo blinds and white curtains in the background.
      Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager
    • A scientist wearing protective clothing, a mask, and safety glasses looks through a microscope in a laboratory setting, with a pen in hand and focused on her research.
      Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment
    • A scientist wearing blue gloves holds a flask with blue liquid in a laboratory, surrounded by various glassware and a microscope in the background.
      Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

    Tags

    awareness biotech advancements Black Flag Racing Brigham and Women’s Hospital Callan Spence Cancer Research Chase Spence Chas Spence CHOP Community Engagement & Partnerships Manager Conference Cure Dr. Rachel Hurly Dr. Ted Laetsch Dr. Theodore W. Laetsch fibroblast fibroblast epigenome grant ground breaking immune-cell therapy innovate treaments JAMA Internal Medicine Julie Kramer Nathan Imperiale National Tumor Board Nature Communications patient advocates patient support Pediatric Oncology Penn Medicine Penn Medicine Synovial Sarcoma Foundation Protein-Blocking Drugs Rare Cancer rare disease research Sarcoma SUMO2 inhibitors Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TAK-981 TECELRA

    Related posts

    A scientist wearing protective clothing, a mask, and safety glasses looks through a microscope in a laboratory setting, with a pen in hand and focused on her research.
    Research, Uncategorized

    Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment

    December 12, 2025 joshs Comments Off on Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment

    In a groundbreaking advancement in cancer treatment, a patient with synovial sarcoma in Arizona has become the first in the state to receive a cutting-edge immune-cell therapy, TECELRA, at the HonorHealth Research Institute in Scottsdale. Synovial sarcoma is a rare soft-tissue cancer that primarily affects large joints in the arms and legs, though it can […]

    A scientist wearing blue gloves holds a flask with blue liquid in a laboratory, surrounded by various glassware and a microscope in the background.
    Research

    Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

    December 4, 2025 joshs Comments Off on Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

    A landmark study just published in Nature Communications finally pinpointed the exact “cell of origin” for synovial sarcoma — a rare, primitive fibroblast that still carries embryonic markers (Hic1⁺ Pdgfra⁺ Lgr5⁺). Breaking 2025 Research: Read the entire article here. Learn more about our world-renowned registry efforts here.

    A stethoscope and a blue pen resting on top of a medical chart with patient information and handwritten notes.
    Latest News, Research

    Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

    September 11, 2025 joshs Comments Off on Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

    The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer. Recent findings published in The EMBO Journal highlight a promising new strategy: using drug blockers to target a problematic protein involved in synovial sarcoma’s genetics. Synovial sarcoma primarily develops in soft tissues such as muscles […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch